Genpact SVP awarded 21,371 RSUs

Genpact Limited reported that Senior Vice President Riju Vashisht received an equity award of 21,371 common-share RSUs on January 30, 2026 at a price of $0 per share, reflecting a stock-based compensation grant rather than an open-market purchase.

Rhea-AI Filing Summary

Genpact Limited reported that Senior Vice President Riju Vashisht received an equity award of 21,371 common-share RSUs on January 30, 2026 at a price of $0 per share, reflecting a stock-based compensation grant rather than an open-market purchase.

Following this award, Vashisht beneficially owns 116,892 Genpact common shares in total. The RSUs vest in three equal installments, with one-third vesting on January 10, 2027, one-third on January 10, 2028, and the final third on January 10, 2029, subject to continued service.

Insider Trade Summary

Grant/Award: 21,371 shares

Grant/Award 1 txn

Insider Vashisht Riju

Role Senior Vice President

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	21,371	$0.00	$0.00

Holdings After Transaction: Common Shares — 116,892 shares (Direct)

Footnotes (1)

1. F1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2027, January 10, 2028 and January 10, 2029, subject to the reporting person's continued service through each vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Genpact (G) disclose about Riju Vashisht in this Form 4?

Genpact disclosed that Senior Vice President Riju Vashisht received an award of 21,371 restricted share units. These RSUs were granted at $0 per share as stock-based compensation, increasing her beneficial ownership to 116,892 Genpact common shares after the reported transaction.

How many Genpact (G) shares does Riju Vashisht own after this RSU grant?

After the RSU grant, Riju Vashisht beneficially owns 116,892 Genpact common shares. This total reflects the newly awarded 21,371 restricted share units alongside previously held shares, as reported in the Form 4 insider trading disclosure filed with regulators.

How do the 21,371 Genpact (G) RSUs granted to Riju Vashisht vest?

The 21,371 RSUs vest in three equal installments over three years. One-third vests on January 10, 2027, another third on January 10, 2028, and the final third on January 10, 2029, conditioned on Vashisht’s continued service through each vesting date.

Was cash paid for the Genpact (G) RSUs granted to Riju Vashisht?

No cash was paid for the RSUs; they were granted at a price of $0 per share. This indicates the award is part of Genpact’s equity compensation program rather than an open-market purchase of common shares by the executive.

Under which plan were the Genpact (G) RSUs granted to Riju Vashisht?

The RSUs were granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each restricted share unit entitles Vashisht to receive one Genpact common share upon vesting, aligning her compensation with the company’s long-term share performance.

What is the role of Riju Vashisht at Genpact (G) according to this filing?

The filing identifies Riju Vashisht as a Senior Vice President of Genpact Limited. Her status as an executive officer requires public reporting of equity awards and other share-related transactions via Form 4, providing transparency into management’s holdings and incentives.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 04:02 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Vashisht Riju

(Last) (First) (Middle)

C/O GENPACT LLC

521 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK NY 10175

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior Vice President

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	01/30/2026		A		21,371(1)	A	$0	116,892	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one Genpact Limited common share upon vesting. One-third of the shares underlying this RSU award will vest on each of January 10, 2027, January 10, 2028 and January 10, 2029, subject to the reporting person's continued service through each vesting date.

Remarks:

	/s/ Thomas D. Scholtes, as Attorney-in-fact for Riju Vashisht	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.